Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.

Young patient inspires gift from stranger

Bob Ripley
Bob Ripley

Summer 2024
By Colleen Sullivan

Bob Ripley reads every issue of Impact cover to cover. While reading the Late Fall 2021 edition, he was very moved by one story in particular.

In early 2020, the family of a 20-year-old woman who passed away from cancer established the Caroline Fund at Dana-Farber in her honor. The fund, which fuels research into a rare and aggressive sarcoma that Caroline had, has drawn support from countless friends and loved ones over the years.

“All I could think about was how young she was,” said Ripley. “This individual missed out on 40 years of a career and a family, and not only that but her mom and dad and siblings have missed out on those milestones, too.”

Philanthropy has always been important to Ripley, and when he comes across a program or an initiative that could have a big impact on people’s lives, he steps up. He is especially passionate about causes that support young people. Though he and Caroline never met, through a provision in his estate plans, Ripley is pledging $500,000 to support the Caroline Fund.

“I have an opportunity to help people—why wouldn’t I want to do that?”

Bob Ripley

“I have an opportunity to help people—why wouldn’t I want to do that?” he said. “Sometimes, I wish I had more resources, and then I’d be able to do even more.”

Research into rare cancers is a key priority of The Dana-Farber Campaign, and philanthropic dollars are critical to move the needle. Investments like Ripley’s help ensure that scientists will have the funding they need to pursue bold ideas—especially important for cancers that currently have limited treatment options.

“A lot of times people look at an organization and say ‘it has plenty of money, it doesn’t need any more,’ but take a look at Dana-Farber and see the many different types of cancers they’re working on,” said Ripley. “There is still so much to do. That’s really my catalyst for giving.”

, , ,

More stories:

Copy link
Powered by Social Snap